durvalumab
astrazeneca
['durvalumab', 'urothelial', 'sakk 06/17']
perioperative chemoimmunotherapy with durvalumab for operable muscle-invasive #urothelialcarcinoma: primary analysis of the single-arm phase ii trial sakk 06/17. presented by richard cathomas, md. #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology